| Cash Flow | 2025-11-01 | 2025-08-02 |
|---|---|---|
| Net income | 96,012 | 59,747 |
| Depreciation and amortization | 108,241 | 69,865 |
| Non-cash operating lease cost | 78,050 | 51,106 |
| Stock-based compensation expense | 35,315 | 24,007 |
| Asset impairments | 5,883 | 3,948 |
| Non-cash finance lease interest expense | 28,883 | 18,193 |
| Product recall | -1,913 | -1,913 |
| Share of equity method investments (income) loss-net | 6,659 | 6,853 |
| Distribution of return on equity method investment | 4,630 | 4,630 |
| Other non-cash items | -4,631 | -2,098 |
| Accounts receivable | -497 | -2,407 |
| Merchandise inventories | -155,251 | -73,595 |
| Prepaid expense and other assets | 21,507 | 13,118 |
| Landlord assets under construction-net of tenant allowances | 64,691 | 46,486 |
| Accounts payable and accrued expenses | -30,070 | -22,239 |
| Deferred revenue and customer deposits | 52,313 | 54,800 |
| Other current liabilities | 12,712 | 13,451 |
| Current and non-current operating lease liabilities | -78,837 | -50,447 |
| Other non-current obligations | -26,392 | -16,298 |
| Net cash provided by operating activities | 356,175 | 224,319 |
| Capital expenditures | 158,387 | 109,565 |
| Acquisition of business | 32,119 | 32,119 |
| Equity method investments | 374 | 374 |
| Acquisition of intangible asset | 3,171 | 3,031 |
| Receipt of promissory note repayment from equity method investee | 1,750 | 1,750 |
| Distribution of return of equity method investment | 7,916 | 7,916 |
| Proceeds from insurance recoveries | 2,325 | 1,275 |
| Net cash used in investing activities | -182,060 | -134,148 |
| Borrowings under asset based credit facility | 290,000 | 260,000 |
| Repayments under asset based credit facility | 425,000 | 325,000 |
| Repayments under term loans | 18,750 | 12,500 |
| Repayments under real estate loans | 254 | 169 |
| Debt issuance costs | 2,997 | 2,766 |
| Principal payments under finance lease agreements-net of tenant allowances | 7,789 | 8,031 |
| Proceeds from exercise of stock options | 2,201 | 1,258 |
| Tax withholdings related to issuance of stock-based awards | 55 | 31 |
| Net cash provided by (used in) financing activities | -162,644 | -87,239 |
| Effects of foreign currency exchange rate translation on cash | 1,202 | 1,215 |
| Net increase (decrease) in cash and cash equivalents | 12,673 | 4,147 |
| Cash and cash equivalents at beginning of period | 30,413 | - |
| Cash and cash equivalents at end of period | 43,086 | - |
RH (RH)
RH (RH)